[go: up one dir, main page]

CN109010823A - Anti- various pathogens composition and its preparation process and application, spray and its preparation process - Google Patents

Anti- various pathogens composition and its preparation process and application, spray and its preparation process Download PDF

Info

Publication number
CN109010823A
CN109010823A CN201810983400.7A CN201810983400A CN109010823A CN 109010823 A CN109010823 A CN 109010823A CN 201810983400 A CN201810983400 A CN 201810983400A CN 109010823 A CN109010823 A CN 109010823A
Authority
CN
China
Prior art keywords
pathogenic bacteria
spray
tinea pedis
multiple pathogenic
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810983400.7A
Other languages
Chinese (zh)
Other versions
CN109010823B (en
Inventor
蒙永祥
农定猛
符美燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Huigao Biotechnology Co ltd
Original Assignee
Hui Gao Bio Tech Ltd Guangzhou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hui Gao Bio Tech Ltd Guangzhou filed Critical Hui Gao Bio Tech Ltd Guangzhou
Priority to CN201810983400.7A priority Critical patent/CN109010823B/en
Publication of CN109010823A publication Critical patent/CN109010823A/en
Application granted granted Critical
Publication of CN109010823B publication Critical patent/CN109010823B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39575Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from other living beings excluding bacteria and viruses, e.g. protozoa, fungi, plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507Comprising a combination of two or more separate antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

一种抗多种致病菌组合物及其制备工艺与应用、喷雾剂及其制备工艺,涉及特异性复合卵黄抗体领域。本发明实施例的抗多种致病菌组合物是采用包括足癣致病菌的抗原免疫得到,足癣致病菌包括红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌,该抗多种致病菌组合物安全,能够预防和治疗足癣;本发明实施例的抗多种致病菌组合物的应用是用于制备预防和治疗足癣的制剂;本发明实施例的喷雾剂及其制备工艺是采用抗多种致病菌组合物制备用于预防和治疗足癣的喷雾剂,用药方便、吸收快、效果显著。An anti-multiple pathogenic bacteria composition and its preparation process and application, a spray and its preparation process relate to the field of specific compound egg yolk antibodies. The anti-multiple pathogenic bacteria composition of the embodiment of the present invention adopts the antigen immunization that comprises tinea pedis pathogenic bacteria to obtain, and tinea pedis pathogenic bacteria comprises Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus coccus, escherichia coli, Pseudomonas aeruginosa, the anti-multiple pathogenic bacteria composition is safe, can prevent and treat tinea pedis; The preparation of tinea pedis; the spray and its preparation process of the embodiment of the present invention is to prepare the spray for preventing and treating tinea pedis by using anti-multiple pathogenic bacteria composition, which is convenient for medication, fast in absorption and remarkable in effect.

Description

抗多种致病菌组合物及其制备工艺与应用、喷雾剂及其制备 工艺Anti-multiple pathogenic bacteria composition and its preparation process and application, spray and its preparation craft

技术领域technical field

本发明涉及特异性复合卵黄抗体领域,且特别涉及一种抗多种致病菌组合物及其制备工艺与应用、喷雾剂及其制备工艺。The invention relates to the field of specific composite egg yolk antibodies, and in particular to an anti-multiple pathogenic bacteria composition and its preparation process and application, spray and its preparation process.

背景技术Background technique

足癣,俗称脚气、香港脚,是致病性真菌引起的足部皮肤病,具有传染性。足癣的发病原因是由于足底和脚趾间没有可分泌抑制真菌的脂肪酸的皮脂腺,而且角质层营养丰富,脚部汗腺丰富,空气流通差,易于形成潮湿温暖的环境,非常利于丝状真菌的生长。妊娠妇女、糖尿病患者或长期使用激素、免疫抑制剂的人群由于皮肤抵抗力的下降,是足癣的易感人群。足癣的主要临床症状包括:剧痒、局部脓肿、皮肤破损、渗液、疼痛,易传染至患者其他部位,如传染至手部形成手癣,感染指甲(趾甲)形成灰指甲,传染至臀部、腹股沟处形成股癣,严重的会引起小腿丹毒等继发感染。Tinea pedis, commonly known as athlete's foot, Hong Kong's athlete's foot, is a foot skin disease caused by pathogenic fungi and is contagious. The cause of tinea pedis is that there are no sebaceous glands that can secrete fatty acids that inhibit fungi between the soles of the feet and the toes, and the stratum corneum is rich in nutrients, sweat glands in the feet are rich, and the air circulation is poor, which is easy to form a humid and warm environment, which is very conducive to the growth of filamentous fungi. grow. Pregnant women, diabetics, or people who have used hormones and immunosuppressants for a long time are susceptible to tinea pedis because of the decline in skin resistance. The main clinical symptoms of tinea pedis include: severe itching, local abscess, skin damage, exudate, pain, easy to infect other parts of the patient, such as infection to the hands to form tinea manuum, infected fingernails (toenails) to form onychomycosis, and infection to the buttocks , Formation of jock itch at the groin, severe cases can cause secondary infections such as calf erysipelas.

目前临床上治疗足癣大多数使用抗真菌药,如1%-2%益康唑霜、咪康唑软膏、克霉唑软膏或其他外用抗真菌药;或者灰黄霉素、酮康唑、伊曲康唑、氟康唑、特比萘芬等内服药。虽然使用抗真菌药有一定的临床疗效,但副作用较大,以消化道反应最常见,长期使用可见肝脏中毒、白细胞减少,中枢神经系统出现不良反应。At present, most antifungal drugs are used in clinical treatment of tinea pedis, such as 1%-2% econazole cream, miconazole ointment, clotrimazole ointment or other topical antifungal drugs; or griseofulvin, ketoconazole, itridine Conazole, fluconazole, terbinafine and other oral medicines. Although the use of antifungal drugs has a certain clinical effect, the side effects are relatively large, and gastrointestinal reactions are the most common. Long-term use can cause liver poisoning, leukopenia, and adverse reactions in the central nervous system.

因此,需要开发一种安全性高,且能够预防和治疗足癣的特效制剂。Therefore, need to develop a kind of high security, and can prevent and treat the specific preparation of tinea pedis.

发明内容Contents of the invention

本发明的目的在于提供一种抗多种致病菌组合物及其制备工艺,该抗多种致病菌组合物安全,能够预防和治疗足癣。The object of the present invention is to provide an anti-multiple pathogenic bacteria composition and its preparation process, the anti-multiple pathogenic bacteria composition is safe and can prevent and treat tinea pedis.

本发明的目的在于提供一种抗多种致病菌组合物的应用,用于制备预防和治疗足癣的制剂。The object of the present invention is to provide an application of the anti-multiple pathogenic bacteria composition for preparing preparations for preventing and treating tinea pedis.

本发明的目的在于提供一种喷雾剂及其制备工艺,采用抗多种致病菌组合物制备用于预防和治疗足癣的喷雾剂,用药方便、吸收快、效果显著。The object of the present invention is to provide a spray and its preparation process. The spray for preventing and treating tinea pedis is prepared by using the anti-multiple pathogenic bacteria composition, which is convenient for medication, fast in absorption and remarkable in effect.

本发明解决其技术问题是采用以下技术方案来实现的。The present invention solves its technical problems by adopting the following technical solutions.

本发明提出一种抗多种致病菌组合物,其是采用包括足癣致病菌的抗原免疫得到,足癣致病菌包括红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌。The present invention proposes an anti-multiple pathogenic bacteria composition, which is obtained by immunizing with antigens comprising tinea pedis pathogenic bacteria, which include Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, aureus Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa.

进一步地,在本发明较佳实施例中,红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌的质量比为 4-8:4-8:3-5:4-8:4-8:3-5。Further, in a preferred embodiment of the present invention, the mass ratio of Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa is 4-8:4-8: 3-5:4-8:4-8:3-5.

进一步地,在本发明较佳实施例中,足癣致病菌还包括洋葱伯克霍尔德菌,红色毛癣菌和洋葱伯克霍尔德菌的质量比为4-8:3-5。Further, in a preferred embodiment of the present invention, the pathogenic bacteria of tinea pedis also includes Burkholderia cepacia, and the mass ratio of Trichophyton rubrum and Burkholderia cepacia is 4-8:3-5 .

本发明提出一种上述的抗多种致病菌组合物的制备工艺,其包括以下步骤:The present invention proposes a preparation process of the above-mentioned anti-multiple pathogenic bacteria composition, which comprises the following steps:

制备包含红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌的复合抗原;Preparation of complex antigens comprising Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa;

用复合抗原对鸡进行强化免疫,得到免疫鸡的免疫鸡蛋;Carry out booster immunization to chickens with compound antigens to obtain immunized eggs of immunized chickens;

将免疫鸡蛋的蛋黄提取获得粗提物干粉;Extracting the yolk of the immunized egg to obtain dry powder of the crude extract;

将粗提物干粉通过离子交换层析和凝胶过滤层析分离纯化,得到抗多种致病菌组合物。The dry powder of the crude extract is separated and purified through ion exchange chromatography and gel filtration chromatography to obtain the anti-multiple pathogenic bacteria composition.

本发明提出一种上述的抗多种致病菌组合物的应用,抗多种致病菌组合物制备用于预防和治疗足癣的制剂,制剂为喷雾剂、乳膏剂或洗剂。The present invention proposes an application of the anti-multiple pathogenic bacteria composition. The anti-multiple pathogenic bacteria composition is used to prepare a preparation for preventing and treating tinea pedis, and the preparation is spray, cream or lotion.

本发明提出一种喷雾剂,其是由原料制备而成,原料包括:The present invention proposes a spray, which is prepared from raw materials, and the raw materials include:

用注射用水补至1000ml。Make up to 1000ml with water for injection.

进一步地,在本发明较佳实施例中,原料还包括1-5g中药提取液,中药提取物是采用包括大蒜、千里光、金银花、虎杖的中草药提取得到。Further, in a preferred embodiment of the present invention, the raw material also includes 1-5 g of Chinese medicine extract, which is obtained by extracting Chinese herbal medicines including garlic, Senecio, honeysuckle and Polygonum cuspidatum.

进一步地,在本发明较佳实施例中,原料还包括1-5g左氧氟沙星。Further, in a preferred embodiment of the present invention, the raw material also includes 1-5 g of levofloxacin.

本发明提出一种上述的喷雾剂的制备工艺,其包括以下步骤:The present invention proposes a kind of preparation technology of above-mentioned spray, it comprises the following steps:

将抗多种致病菌组合物、悬浮剂加入部分注射用水中搅拌溶解,得到混合液;adding the anti-multiple pathogenic bacteria composition and suspending agent into part of the water for injection and stirring to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml,得到药液;Dissolve the borneol in ethanol, then add glycerin to mix, then add the mixed solution, and finally make up to 1000ml with water for injection to obtain the medicinal solution;

将药液在灌装线上灌装手动定量压力喷雾罐50支,每支20ml,再充入30%以上的抛射剂。Fill 50 manual quantitative pressure spray tanks with the medicinal liquid on the filling line, each 20ml, and then fill in more than 30% of the propellant.

进一步地,在本发明较佳实施例中,制备混合液时还加入1-5g 中药提取液,中药提取液的具体制备方法为:Further, in a preferred embodiment of the present invention, 1-5 g of Chinese medicine extract is also added when preparing the mixed solution, and the specific preparation method of the Chinese medicine extract is as follows:

将清洗后的大蒜、千里光、金银花、虎杖用水提取至少两次,合并提取液经高速离心机离心,得第一离心液;Extracting the washed garlic, senecio, honeysuckle, and knotweed with water at least twice, and centrifuging the combined extracts in a high-speed centrifuge to obtain the first centrate;

将水提后的药渣用乙醇溶液回流提取至少一次,提取液经高速离心机离心,得第二离心液;The medicinal dregs after water extraction are extracted at least once with ethanol solution under reflux, and the extract is centrifuged in a high-speed centrifuge to obtain a second centrate;

合并第一离心液和第二离心液,得到中药提取液。The first centrifugate and the second centrifuge are combined to obtain a traditional Chinese medicine extract.

本发明实施例的抗多种致病菌组合物及其制备工艺与应用、喷雾剂及其制备工艺的有益效果是:本发明实施例的抗多种致病菌组合物是采用包括足癣致病菌的抗原免疫得到,足癣致病菌包括红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌,该抗多种致病菌组合物安全,能够预防和治疗足癣;本发明实施例的抗多种致病菌组合物的应用是用于制备预防和治疗足癣的制剂;本发明实施例的喷雾剂及其制备工艺是采用抗多种致病菌组合物制备用于预防和治疗足癣的喷雾剂,用药方便、吸收快、效果显著。The beneficial effects of the anti-multiple pathogenic bacteria composition and its preparation process and application, spray and its preparation process of the embodiment of the present invention are: the anti-multiple pathogenic bacteria composition of the embodiment of the present invention adopts the The antigen immunization of pathogenic bacteria is obtained, and the pathogenic bacteria of tinea pedis include Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and the anti-multiple pathogenic bacteria composition is safe , can prevent and treat tinea pedis; the application of the anti-multiple pathogenic bacteria composition of the present invention is to prepare the preparation for preventing and treating tinea pedis; The spray used for preventing and treating tinea pedis is prepared from the pathogenic bacteria composition, and has the advantages of convenient medication, fast absorption and remarkable effect.

具体实施方式Detailed ways

为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Those who do not indicate the specific conditions in the examples are carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used were not indicated by the manufacturer, and they were all conventional products that could be purchased from the market.

下面对本发明实施例的抗多种致病菌组合物及其制备工艺与应用、喷雾剂及其制备工艺进行具体说明。The anti-multiple pathogenic bacteria composition of the embodiment of the present invention and its preparation process and application, spray and its preparation process will be described in detail below.

本发明实施例提供一种抗多种致病菌组合物,其是采用包括足癣致病菌的抗原免疫得到,具体是采用足癣致病菌制备复合抗原,并将复合抗原对鸡进行强化免疫,从得到的免疫鸡的免疫鸡蛋的蛋黄提纯得到。足癣致病菌包括红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌,且红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌的质量比一般为 4-8:4-8:3-5:4-8:4-8:3-5。The embodiment of the present invention provides an anti-multiple pathogenic bacteria composition, which is obtained by immunizing with antigens including tinea pedis pathogenic bacteria, specifically preparing composite antigens by using tinea pedis pathogenic bacteria, and strengthening the chicken with the composite antigens The immunization is obtained by purifying the yolk of the immunized eggs of the obtained immunized chickens. The pathogenic bacteria of tinea pedis include Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, The mass ratio of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa is generally 4-8:4-8:3-5:4-8:4-8:3-5.

在本发明的一些实施例中,足癣致病菌还可以包括洋葱伯克霍尔德菌(保藏号ATCC25608),红色毛癣菌和洋葱伯克霍尔德菌的质量比为4-8:3-5。抗多种致病菌组合物即为抗上述足癣致病菌的复合抗体提取物,抗多种致病菌组合物对导致足癣的多种病原微生物,有特异性结合抑杀作用,即使在浓度极低的情况下,也能起到有效作用,并且只抑杀病原菌,更不会产生耐药菌株,对人体也未发现毒副作用。In some embodiments of the present invention, the athlete's foot pathogen can also include Burkholderia cepacia (preservation number ATCC25608), and the mass ratio of Trichophyton rubrum and Burkholderia cepacia is 4-8: 3-5. The anti-multiple pathogenic bacteria composition is the compound antibody extract against the above-mentioned tinea pedis pathogenic bacteria, and the anti-multiple pathogenic bacteria composition has a specific binding inhibitory effect on various pathogenic microorganisms that cause tinea pedis. In the case of extremely low concentration, it can also play an effective role, and it only inhibits and kills pathogenic bacteria, and it will not produce drug-resistant strains, and no toxic side effects have been found on the human body.

本发明实施例提供一种抗多种致病菌组合物的制备工艺,其包括以下步骤:The embodiment of the present invention provides a preparation process of a composition against various pathogenic bacteria, which comprises the following steps:

S1、制备包含红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌等足癣致病菌的复合抗原。S1. Prepare a complex antigen containing Tinea pedis pathogenic bacteria such as Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and the like.

具体是分别将红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌在34-36℃条件下恒温培养20-24h,再灭活备用;将已灭活的红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌按照质量比 4-8:4-8:3-5:4-8:4-8:3-5混匀得到菌株混合体;将菌株混合体溶解在中性、0.08-0.1mol/L的PBS溶液中,制得浓度为1.2-2.2mg/mL的菌株混合体溶液;在菌株混合体溶液中等体积加入弗氏佐剂,高速均质,即得复合抗原。Specifically, Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa were cultured at a constant temperature of 34-36°C for 20-24 hours, and then inactivated for later use; Inactivated Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa according to mass ratio 4-8:4-8:3-5:4-8:4- 8:3-5 mixing to obtain a strain mixture; dissolve the strain mixture in a neutral, 0.08-0.1mol/L PBS solution to obtain a strain mixture solution with a concentration of 1.2-2.2mg/mL; Add Freund's adjuvant in medium volume to the mixture solution, and homogenize at high speed to obtain the composite antigen.

S2、用复合抗原对鸡进行强化免疫,得到免疫鸡的免疫鸡蛋。S2. Carrying out booster immunization to chickens with compound antigens to obtain immunized eggs of immunized chickens.

具体是将复合抗原注射在20周大的鸡的胸肌和大腿处,每处分别注射0.5-0.6ml,然后每隔10天强化注射一次,共免疫至少3次。首次注射时所用的复合抗原中的弗氏佐剂为弗氏不完全佐剂,第二次以后所采用的复合抗原中的弗氏佐剂为完全弗氏佐剂,最后一次注射后收集经过强化免疫的鸡所产的鸡蛋。Specifically, the compound antigen is injected into the breast muscle and thigh of 20-week-old chickens, each site is injected with 0.5-0.6ml, and then boosted once every 10 days, with a total of at least 3 immunizations. The Freund's adjuvant in the compound antigen used for the first injection was incomplete Freund's adjuvant, the Freund's adjuvant in the compound antigen used after the second time was complete Freund's adjuvant, and the collection after the last injection was strengthened. Eggs laid by immunized chickens.

本实施例中进行强化免疫的鸡为海兰褐鸡、京红鸡、伊莎白鸡和白来航蛋鸡中的一种;为了使制得的抗多种致病菌组合物质量更好,进行强化免疫的鸡通过如下方法选择:第一次注射后第7个月,把这些鸡所产的蛋标记后分别提取其中的IgY,以ELISA法检测所制得的IgY的效价;再比较其效价,选出其中能制得IgY效价≥1:128的鸡,再用这批鸡所产的蛋孵出鸡种,待其长大至20周,作为进行强化免疫的鸡。Carry out the chicken of booster immunity in the present embodiment is a kind of in Hailan brown chicken, Beijing red chicken, Isabeth chicken and Bailaihang laying hen; Carry out the chicken of booster immunization by following method selection: the 7th month after the first injection, mark the eggs produced by these chickens and extract the IgY therein respectively, detect the potency of the prepared IgY with ELISA method; For its titer, select the chickens that can produce IgY titer ≥ 1:128, and then use the eggs produced by these chickens to hatch chicken breeds, and wait for them to grow up to 20 weeks, as chickens for enhanced immunization.

S3、将免疫鸡蛋的蛋黄提纯获得粗提物干粉。S3. Purifying the egg yolk of the immunized egg to obtain dry powder of the crude extract.

具体是用打蛋机将免疫鸡蛋打碎,除去蛋清,将蛋黄搅拌均匀,按蛋黄体积的4-6倍加入蒸馏水稀释并混合均匀,调试pH至5.0-6.0;然后冷却至2-6℃,静置12-24h;之后经高速离心分离机离心分离 20-30分钟;将分离所得的上清再加入超滤器中进行超滤并浓缩10-20 倍,将质量浓度为10%-13%的硫酸钠溶液加入到浓缩后的浆料中充分搅拌;再经高速离心机离心分离,取上清,除去脂蛋白,得到浆料;将浆料加入超滤机中过超微膜以过滤除菌;将过滤除菌后的浆料用冷冻干燥机进行冷冻干燥,制得粗提物干粉。Specifically, use an egg beater to break the immunized egg, remove the egg white, stir the egg yolk evenly, add distilled water to dilute and mix evenly according to the volume of the egg yolk 4-6 times, adjust the pH to 5.0-6.0; then cool to 2-6°C, Stand still for 12-24 hours; then centrifuge through a high-speed centrifuge for 20-30 minutes; add the separated supernatant to an ultrafilter for ultrafiltration and concentrate 10-20 times, and the mass concentration is 10%-13% Add the sodium sulfate solution into the concentrated slurry and stir thoroughly; then centrifuge through a high-speed centrifuge, take the supernatant, remove lipoproteins, and obtain the slurry; add the slurry to an ultrafiltration machine to pass through an ultrafine membrane to filter out Bacteria; freeze-dry the slurry after filtering and sterilizing with a freeze dryer to obtain dry powder of the crude extract.

S4、将粗提物干粉经离子交换柱进行离子交换层析和凝胶交换柱进行凝胶过滤层析以分离纯化,得到抗多种致病菌组合物。S4. The dry powder of the crude extract is subjected to ion-exchange chromatography on an ion-exchange column and gel filtration chromatography on a gel-exchange column to separate and purify to obtain an anti-multiple pathogenic bacteria composition.

本发明实施例提供一种上述的抗多种致病菌组合物的应用,抗多种致病菌组合物制备用于预防和治疗足癣的制剂,制剂剂型可以是喷雾剂、乳膏剂、洗剂。The embodiment of the present invention provides a kind of application of above-mentioned anti-multiple pathogenic bacteria composition, anti-multiple pathogenic bacteria composition prepares the preparation that is used for preventing and treating tinea pedis, and the dosage form of preparation can be spray, cream, lotion agent.

本发明实施例提供一种喷雾剂,其是由原料制备而成,原料包括: 0.5-1.5g抗多种致病菌组合物;20-25g甘油;3-5g冰片;10-15g悬浮剂;5-10ml乙醇;用注射用水补至1000ml。悬浮剂包括微晶纤维素、羧甲基纤维素钠中的至少一种。The embodiment of the present invention provides a spray, which is prepared from raw materials, and the raw materials include: 0.5-1.5g anti-multiple pathogenic bacteria composition; 20-25g glycerin; 3-5g borneol; 10-15g suspending agent; 5-10ml ethanol; make up to 1000ml with water for injection. The suspending agent includes at least one of microcrystalline cellulose and sodium carboxymethyl cellulose.

在本发明的一些实施例中,原料还可以包括1-5g中药提取液,中药提取物是采用包括大蒜、千里光、金银花、虎杖的中草药提取得到。本实施例采用的中草药中,大蒜外用具有抗菌、抗病毒及抗原虫的作用;千里光、金银花和虎杖均具有清热解毒的作用,主治痈肿疮毒。将大蒜、千里光、金银花、虎杖提取制成中药提取物,能够增强产品的抗菌效果,且可增加止痒作用。In some embodiments of the present invention, the raw material may also include 1-5 g of Chinese medicine extract, which is obtained by extracting Chinese herbal medicines including garlic, Senecio, honeysuckle, and Polygonum cuspidatum. Among the Chinese herbal medicines used in this example, garlic for external use has antibacterial, antiviral and antiprotozoal effects; Senecio, honeysuckle and knotweed all have the effects of clearing away heat and detoxification, and are mainly used to treat carbuncle and sore. Garlic, Senecio, Honeysuckle, and Polygonum cuspidatum are extracted to make traditional Chinese medicine extracts, which can enhance the antibacterial effect of the product and increase the antipruritic effect.

在本发明的一些实施例中,原料还可以包括1-5g左氧氟沙星,左氧氟沙星作为一种广谱的抗菌药,对多数肠杆菌科细菌有较强的抗菌活性,对金黄色葡萄球菌也有抗菌作用,添加左氧氟沙星能增强产品的抗菌作用,从而具有更好的治疗足癣效果。In some embodiments of the present invention, the raw material can also include 1-5g of levofloxacin, levofloxacin, as a broad-spectrum antibacterial drug, has strong antibacterial activity against most Enterobacteriaceae bacteria, and also has an antibacterial effect on Staphylococcus aureus, Adding levofloxacin can enhance the antibacterial effect of the product, thereby having a better effect on treating tinea pedis.

本实施例的喷雾剂使用中药提取物、左氧氟沙星(西药)中的至少一种与抗多种致病菌组合物协同作用,可进一步增大抗菌谱,从而达到治疗足癣的目的。The spray of this embodiment uses at least one of traditional Chinese medicine extracts and levofloxacin (western medicine) to act synergistically with the anti-multiple pathogenic bacteria composition, which can further increase the antibacterial spectrum, thereby achieving the purpose of treating tinea pedis.

本发明实施例提供一种上述的喷雾剂的制备工艺,其包括以下步骤:The embodiment of the present invention provides a preparation process of the above-mentioned spray, which comprises the following steps:

将抗多种致病菌组合物、悬浮剂加入部分注射用水中搅拌溶解,得到混合液;adding the anti-multiple pathogenic bacteria composition and suspending agent into part of the water for injection and stirring to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml;Dissolve borneol in ethanol, then add glycerin and mix well, then add the mixture, and finally make up to 1000ml with water for injection;

在灌装线上管转手动定量压力喷雾罐50支,每支20ml,再充入抛射剂质量占30%以上。On the filling line, transfer 50 manual quantitative pressure spray cans, each 20ml, and then fill the propellant with a mass of more than 30%.

在本发明的一些实施例中,制备混合液时还加入1-5g中药提取液,中药提取液的具体制备方法为:In some embodiments of the present invention, when preparing the mixed solution, 1-5 g of Chinese medicine extract is added, and the specific preparation method of the Chinese medicine extract is as follows:

将清洗后的大蒜、千里光、金银花、虎杖用水提取至少两次,合并提取液经高速离心机离心,得第一离心液;Extracting the washed garlic, senecio, honeysuckle, and knotweed with water at least twice, and centrifuging the combined extracts in a high-speed centrifuge to obtain the first centrate;

将水提后的药渣用乙醇溶液回流提取至少一次,提取液经高速离心机离心,得第二离心液;The medicinal dregs after water extraction are extracted at least once with ethanol solution under reflux, and the extract is centrifuged in a high-speed centrifuge to obtain a second centrate;

合并第一离心液和第二离心液,得到中药提取液。The first centrifugate and the second centrifuge are combined to obtain a traditional Chinese medicine extract.

以下结合实施例对本发明的特征和性能作进一步地详细描述。The characteristics and performance of the present invention are described in further detail below in conjunction with the examples.

实施例1Example 1

本实施例提供一种抗多种致病菌组合物,其是按照以下过程制得:The present embodiment provides an anti-multiple pathogenic bacteria composition, which is prepared according to the following process:

分别将红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌接种到Luria-Bertani培养基中,Luria-Bertani 培养基按质量百分数计包括2%的胰蛋白胨、1%的酵母提取物、1%的氯化钠和1.5%的琼脂,在35℃环境下用在三气培养箱中培养22h,然后将上述菌种分离并接种到肉汤培养基中,肉汤培养基按质量百分数计包括1%的牛肉提取物、2%的胰蛋白胨、0.5%的氯化钠、1.5%的琼脂,在35℃环境下在恒温振荡培养箱中培养26h,恒温振荡培养箱的转速为180rpm,然后灭活备用;将已灭活的红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌按重量比6:6:4:6:6:4混匀得到菌株混合体;将菌株混合体溶解在中性、 0.09mol/L的PBS溶液中制得菌株混合体溶液,制得浓度为1.8mg/mL 的菌株混合体溶液;在菌株混合体溶液中等体积加入弗氏佐剂搅拌均匀,制得乳状的全菌复合抗原;将全菌复合抗原放入高速匀浆机中,高速粉碎匀化,制得复合抗原。Inoculate Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa into Luria-Bertani medium respectively, and Luria-Bertani medium includes 2% of Tryptone, 1% yeast extract, 1% sodium chloride and 1.5% agar were used to culture in a tri-gas incubator for 22 hours at 35°C, and then the above strains were isolated and inoculated into broth medium In the medium, the broth medium includes 1% beef extract, 2% tryptone, 0.5% sodium chloride, and 1.5% agar in terms of mass percentages, and is cultivated in a constant temperature shaking incubator at 35°C for 26 hours. The rotating speed of the constant temperature shaking incubator is 180rpm, then inactivation is standby; With inactivated Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa by weight ratio 6: Mix 6:4:6:6:4 to obtain a strain mixture; dissolve the strain mixture in a neutral, 0.09mol/L PBS solution to prepare a strain mixture solution, and obtain a strain with a concentration of 1.8mg/mL Mixture solution; add Freund's adjuvant in an equal volume to the strain mixture solution and stir evenly to obtain a milky whole-bacteria composite antigen; put the whole-bacteria composite antigen into a high-speed homogenizer, crush and homogenize at a high speed to obtain a composite antigen .

将制得的复合抗原注射在20周大的鸡的胸肌和大腿处,每处分别注射0.5ml,然后每隔10天强化注射一次,共免疫四次。首次注射时所用的弗氏佐剂为弗氏不完全佐剂,第二次到第四次所采用的弗氏佐剂为完全弗氏佐剂,在最后一次注射后收集经过强化免疫的鸡所产的鸡蛋。The prepared composite antigen was injected into the pectoralis muscle and thigh of 20-week-old chickens, 0.5ml was injected into each place, and then boosted once every 10 days, and immunized four times in total. The Freund's adjuvant used for the first injection was incomplete Freund's adjuvant, and the Freund's adjuvant used for the second to fourth times was complete Freund's adjuvant. After the last injection, the chickens that had been boosted were collected Lay eggs.

用打蛋机将免疫鸡蛋打碎,除去蛋清,将蛋黄搅拌均匀,按蛋黄体积的5倍加入蒸馏水稀释并混合均匀,调试pH至6.0;然后冷却至4℃,静置20h;之后经高速离心分离机离心分离25分钟;将分离所得的上清再加入超滤器中进行超滤并浓缩15倍,将质量浓度为 11%的硫酸钠溶液加入到浓缩后的浆料中充分搅拌;再经高速离心机离心分离,取上清,除去脂蛋白,得到浆料;将浆料加入超滤机中过超微膜以过滤除菌;将过滤除菌后的浆料用冷冻干燥机进行冷冻干燥,制得粗提物干粉。Break the immunized eggs with an egg beater, remove the egg whites, stir the egg yolks evenly, add distilled water to dilute and mix evenly according to 5 times the volume of the egg yolks, adjust the pH to 6.0; then cool to 4°C, let stand for 20 hours; then centrifuge at high speed The separator was centrifuged for 25 minutes; the separated supernatant was added to an ultrafilter for ultrafiltration and concentrated 15 times, and the sodium sulfate solution with a mass concentration of 11% was added to the concentrated slurry and fully stirred; Centrifuge with a high-speed centrifuge, take the supernatant, remove lipoproteins, and obtain a slurry; put the slurry into an ultrafiltration machine to pass through an ultra-micro membrane to filter and sterilize; freeze-dry the filtered and sterilized slurry with a freeze dryer , to obtain dry powder of crude extract.

将粗提物干粉经离子交换柱进行离子交换层析和凝胶交换柱进行凝胶过滤层析以分离纯化,得到抗多种致病菌组合物。The dry powder of the crude extract is subjected to ion-exchange chromatography through an ion-exchange column and gel filtration chromatography through a gel-exchange column to separate and purify the composition to obtain an anti-multiple pathogenic bacteria composition.

实施例2Example 2

本实施例提供一种抗多种致病菌组合物,其是按照以下过程制得:The present embodiment provides an anti-multiple pathogenic bacteria composition, which is prepared according to the following process:

分别将红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌、洋葱伯克霍尔德菌接种到Luria-Bertani 培养基中,Luria-Bertani培养基按质量百分数计包括2%的胰蛋白胨、 1%的酵母提取物、1%的氯化钠和1.5%的琼脂,在36℃环境下用在三气培养箱中培养20h,然后将上述菌种分离并接种到肉汤培养基中,肉汤培养基按质量百分数计包括1%的牛肉提取物、2%的胰蛋白胨、0.5%的氯化钠、1.5%的琼脂,在34℃环境下在恒温振荡培养箱中培养30h,恒温振荡培养箱的转速为200rpm,然后灭活备用;将已灭活的红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌、洋葱伯克霍尔德菌按重量比8:8:3:4:4:3:4混匀得到菌株混合体;将菌株混合体溶解在中性、0.1mol/L的PBS溶液中制得菌株混合体溶液,制得浓度为2.2mg/mL的菌株混合体溶液;在菌株混合体溶液中等体积加入弗氏佐剂搅拌均匀,制得乳状的全菌复合抗原;将全菌复合抗原放入高速匀浆机中,高速粉碎匀化,制得复合抗原。Inoculate Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Burkholderia cepacia into Luria-Bertani medium, Luria-Bertani medium Including 2% tryptone, 1% yeast extract, 1% sodium chloride and 1.5% agar by mass percentage, cultivated in a tri-gas incubator at 36°C for 20h, and then the above bacterial species Separate and inoculate in the broth medium, the broth medium includes 1% beef extract, 2% tryptone, 0.5% sodium chloride, 1.5% agar in terms of mass percentage, at 34 ℃ Cultivate in a constant temperature shaking incubator for 30 hours, and the rotating speed of the constant temperature shaking incubator is 200rpm, then inactivate for later use; the inactivated Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Burkholderia cepacia were mixed in a weight ratio of 8:8:3:4:4:3:4 to obtain a strain mixture; the strain mixture was dissolved in a neutral, 0.1mol/L PBS solution The strain mixture solution was prepared in , and the strain mixture solution with a concentration of 2.2 mg/mL was prepared; Freund's adjuvant was added in an equal volume to the strain mixture solution and stirred evenly to obtain a milky whole bacteria composite antigen; the whole bacteria composite Put the antigen into a high-speed homogenizer, pulverize and homogenize at a high speed, and obtain a composite antigen.

将制得的复合抗原注射在20周大的鸡的胸肌和大腿处,每处分别注射0.6ml,然后每隔10天强化注射一次,共免疫四次。首次注射时所用的弗氏佐剂为弗氏不完全佐剂,第二次到第四次所采用的弗氏佐剂为完全弗氏佐剂,在最后一次注射后收集经过强化免疫的鸡所产的鸡蛋。The prepared composite antigen was injected into the pectoralis muscle and thigh of 20-week-old chickens, 0.6ml was injected into each place, and then boosted once every 10 days, and immunized four times in total. The Freund's adjuvant used for the first injection was incomplete Freund's adjuvant, and the Freund's adjuvant used for the second to fourth times was complete Freund's adjuvant. After the last injection, the chickens that had been boosted were collected Lay eggs.

用打蛋机将免疫鸡蛋打碎,除去蛋清,将蛋黄搅拌均匀,按蛋黄体积的6倍加入蒸馏水稀释并混合均匀,调试pH至5.0;然后冷却至6℃,静置15h;之后经高速离心分离机离心分离20分钟;将分离所得的上清再加入超滤器中进行超滤并浓缩10倍,将质量浓度为 10%的硫酸钠溶液加入到浓缩后的浆料中充分搅拌;再经高速离心机离心分离,取上清,除去脂蛋白,得到浆料;将浆料加入超滤机中过超微膜以过滤除菌;将过滤除菌后的浆料用冷冻干燥机进行冷冻干燥,制得粗提物干粉。Break the immunized eggs with an egg beater, remove the egg whites, stir the egg yolks evenly, add distilled water to dilute and mix evenly according to 6 times the volume of the egg yolks, adjust the pH to 5.0; then cool to 6°C and let stand for 15 hours; then centrifuge at high speed The separator was centrifuged for 20 minutes; the separated supernatant was added to an ultrafilter for ultrafiltration and concentrated 10 times, and the sodium sulfate solution with a mass concentration of 10% was added to the concentrated slurry to fully stir; Centrifuge with a high-speed centrifuge, take the supernatant, remove lipoproteins, and obtain a slurry; put the slurry into an ultrafiltration machine to pass through an ultra-micro membrane to filter and sterilize; freeze-dry the filtered and sterilized slurry with a freeze dryer , to obtain dry powder of crude extract.

将粗提物干粉经离子交换柱进行离子交换层析和凝胶交换柱进行凝胶过滤层析以分离纯化,得到抗多种致病菌组合物。The dry powder of the crude extract is subjected to ion-exchange chromatography through an ion-exchange column and gel filtration chromatography through a gel-exchange column to separate and purify the composition to obtain an anti-multiple pathogenic bacteria composition.

实施例3Example 3

本实施例提供一种喷雾剂,其是按照以下制备过程制得:The present embodiment provides a spray, which is prepared according to the following preparation process:

准备原料:1g实施例1中的抗多种致病菌组合物;20g甘油;4g 冰片;10g微晶纤维素;6ml乙醇;注射用水。Prepare raw materials: 1g of the anti-multiple pathogenic bacteria composition in Example 1; 20g of glycerin; 4g of borneol; 10g of microcrystalline cellulose; 6ml of ethanol; water for injection.

将抗多种致病菌组合物、微晶纤维素加入500ml注射用水中搅拌溶解,得到混合液;Add the anti-multiple pathogenic bacteria composition and microcrystalline cellulose into 500ml of water for injection and stir to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml;Dissolve borneol in ethanol, then add glycerin and mix well, then add the mixture, and finally make up to 1000ml with water for injection;

在灌装线上管转手动定量压力喷雾罐50支,每支20ml,再充入抛射剂30%以上。On the filling line, transfer 50 manual quantitative pressure spray cans, each 20ml, and then fill more than 30% of the propellant.

实施例4Example 4

本实施例提供一种喷雾剂,其是按照以下制备过程制得:The present embodiment provides a spray, which is prepared according to the following preparation process:

1g实施例1中的抗多种致病菌组合物;20g甘油;3g冰片;10g 羧甲基纤维素钠;5ml乙醇;2g中药提取液(由大蒜、千里光、金银花、虎杖提取得到);注射用水。1g anti-multiple pathogenic bacteria composition in embodiment 1; 20g glycerin; 3g borneol; 10g sodium carboxymethylcellulose; 5ml ethanol; 2g Chinese medicine extract (obtained by garlic, Senecio, honeysuckle, Polygonum cuspidatum extraction); Water for Injection.

将抗多种致病菌组合物、中药提取液、羧甲基纤维素钠加入 600ml注射用水中搅拌溶解,得到混合液;Add the anti-multiple pathogenic bacteria composition, traditional Chinese medicine extract, and sodium carboxymethylcellulose into 600ml of water for injection and stir to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml;Dissolve borneol in ethanol, then add glycerin and mix well, then add the mixture, and finally make up to 1000ml with water for injection;

在灌装线上管转手动定量压力喷雾罐50支,每支20ml,再充入抛射剂30%以上。On the filling line, transfer 50 manual quantitative pressure spray cans, each 20ml, and then fill more than 30% of the propellant.

实施例5Example 5

本实施例提供一种喷雾剂,其是按照以下制备过程制得:The present embodiment provides a spray, which is prepared according to the following preparation process:

1g实施例2中的抗多种致病菌组合物;20g甘油;3g冰片;10g 微晶纤维素;5ml乙醇;2g左氧氟沙星;注射用水。1g anti-multiple pathogenic bacteria composition in Example 2; 20g glycerin; 3g borneol; 10g microcrystalline cellulose; 5ml ethanol; 2g levofloxacin; water for injection.

将抗多种致病菌组合物、左氧氟沙星、羧甲基纤维素钠加入 600ml注射用水中搅拌溶解,得到混合液;Add the anti-multiple pathogenic bacteria composition, levofloxacin, and sodium carboxymethylcellulose into 600ml of water for injection and stir to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml;Dissolve borneol in ethanol, then add glycerin and mix well, then add the mixture, and finally make up to 1000ml with water for injection;

在灌装线上管转手动定量压力喷雾罐50支,每支20ml,再充入抛射剂30%以上。On the filling line, transfer 50 manual quantitative pressure spray cans, each 20ml, and then fill more than 30% of the propellant.

实施例6Example 6

本实施例提供一种喷雾剂,其是按照以下制备过程制得:The present embodiment provides a spray, which is prepared according to the following preparation process:

1g实施例2中的抗多种致病菌组合物;22g甘油;4g冰片;12g 羧甲基纤维素钠;6ml乙醇;1g中药提取液(由大蒜、千里光、金银花、虎杖提取得到);1g左氧氟沙星;注射用水。1g anti-multiple pathogenic bacteria composition in embodiment 2; 22g glycerin; 4g borneol; 12g sodium carboxymethylcellulose; 6ml ethanol; 1g Chinese medicine extract (obtained by extracting garlic, Senecio, honeysuckle, Polygonum cuspidatum); 1g levofloxacin; water for injection.

将抗多种致病菌组合物、中药提取液、左氧氟沙星、羧甲基纤维素钠加入600ml注射用水中搅拌溶解,得到混合液;Add the anti-multiple pathogenic bacteria composition, traditional Chinese medicine extract, levofloxacin, and sodium carboxymethylcellulose into 600ml of water for injection and stir to dissolve to obtain a mixed solution;

将冰片加乙醇溶解,再加入甘油混匀,再加入混合液,最后用注射用水补足至1000ml;Dissolve borneol in ethanol, then add glycerin and mix well, then add the mixture, and finally make up to 1000ml with water for injection;

在灌装线上管转手动定量压力喷雾罐50支,每支20ml,再充入抛射剂30%以上。On the filling line, transfer 50 manual quantitative pressure spray cans, each 20ml, and then fill more than 30% of the propellant.

以下通过试验对本发明实施例的喷雾剂的性能及治疗效果进行考察。The performance and therapeutic effects of the sprays of the embodiments of the present invention are investigated through tests below.

一、皮肤毒性试验:取健康成年家兔30只,分为5组,每组包括完整皮肤和破损皮肤各3只,其中1组为空白对照组,不作任何处理;另外4组为试验组,分别用实施例3-6的喷雾剂对应喷4组试验组的家兔,每只兔子每天喷足部3次,每次3喷,持续7天。测定所有家兔的呼吸、心率和四肢活动等。1. Skin toxicity test: Take 30 healthy adult rabbits and divide them into 5 groups. Each group includes 3 intact skins and 3 damaged skins. One group is a blank control group without any treatment; the other 4 groups are test groups. The sprays of Examples 3-6 were used to spray 4 groups of rabbits in the test group respectively, and each rabbit was sprayed 3 times a day, 3 sprays each time, for 7 days. The respiration, heart rate and limb activity of all rabbits were measured.

结果显示,试验组和空白对照组的统计上无显著性差异,并未发现全身性毒副反应。The results showed that there was no statistically significant difference between the test group and the blank control group, and no systemic toxic and side effects were found.

二、临床试验2. Clinical trials

选取100例足癣患者,症状:趾间糜烂、水泡、恶臭、瘙痒,患者年龄范围30-60岁,男60例,女40例。疗效标准如下:Select 100 cases of tinea pedis patients, symptoms: interdigital erosion, blisters, stench, itching, patients age range 30-60 years old, 60 cases of males, 40 cases of females. The curative effect standard is as follows:

治愈:足部糜烂干燥、无痒感、无水泡、脱屑;Cure: the feet are erosive and dry, no itching, no blisters, no desquamation;

有效:水泡减少、痒感减轻、有轻微脱屑;Effective: less blisters, less itching, slight desquamation;

无效:无明显效果,水泡增加,局部痒感、脱屑。Ineffective: No obvious effect, increased blisters, local itching, and desquamation.

将100例足癣患者分为5组,分别为对照组和试验组1-4,对照组不作任何处理,试验组1-4对应采用实施例3-6的喷雾剂治疗。治疗方法是:采用喷雾剂对足癣患者的足部喷药,每天用药3次,每次用药按压3喷。用药两周后统计各组治疗效果,如表1所示。100 routine tinea pedis patients were divided into 5 groups, which were respectively control group and test group 1-4. The control group was not given any treatment, and test group 1-4 was correspondingly treated with the spray of embodiment 3-6. Therapeutic method is: adopt spray to spray medicine to the foot of tinea pedis patient, take medicine 3 times every day, press 3 sprays every time medicine. The treatment effects of each group were counted after two weeks of medication, as shown in Table 1.

表1足癣治疗效果Table 1 Tinea pedis treatment effect

由上表可知,由本发明实施例的抗多种致病菌组合物制得的喷雾剂对足癣的治疗有效率达90%以上,疗效显著。It can be seen from the above table that the effective rate of treating tinea pedis of the spray prepared by the anti-multiple pathogenic bacteria composition of the embodiment of the present invention is more than 90%, and the curative effect is remarkable.

综上所述,本发明实施例的抗多种致病菌组合物安全,能够预防和治疗足癣;本发明实施例的抗多种致病菌组合物的应用是用于制备预防和治疗足癣的制剂;本发明实施例的喷雾剂及其制备工艺是采用抗多种致病菌组合物制备用于预防和治疗足癣的喷雾剂,用药方便、吸收快、效果显著。In summary, the anti-multiple pathogenic bacteria compositions of the embodiments of the present invention are safe and can prevent and treat tinea pedis; The preparation of tinea pedis; the spray and its preparation process of the embodiment of the present invention is to prepare the spray for preventing and treating tinea pedis by using anti-multiple pathogenic bacteria composition, which is convenient for medication, fast in absorption and remarkable in effect.

以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The embodiments described above are some, not all, embodiments of the present invention. The detailed description of the embodiments of the invention is not intended to limit the scope of the claimed invention but to represent only selected embodiments of the invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

Claims (10)

1.一种抗多种致病菌组合物,其特征在于,其是采用包括足癣致病菌的抗原免疫得到,所述足癣致病菌包括红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌。1. an anti-multiple pathogenic bacteria composition is characterized in that, it adopts the antigen immunization that comprises tinea pedis pathogenic bacteria to obtain, and described tinea pedis pathogenic bacteria comprises Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa. 2.根据权利要求1所述的抗多种致病菌组合物,其特征在于,所述红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌的质量比分别为4-8:4-8:3-5:4-8:4-8:3-5。2. anti-multiple pathogenic bacteria compositions according to claim 1, is characterized in that, described Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa The mass ratios are 4-8:4-8:3-5:4-8:4-8:3-5, respectively. 3.根据权利要求1所述的抗多种致病菌组合物,其特征在于,所述足癣致病菌还包括洋葱伯克霍尔德菌,所述红色毛癣菌和所述洋葱伯克霍尔德菌的质量比为4-8:3-5。3. anti-multiple pathogenic bacteria compositions according to claim 1, is characterized in that, described tinea pedis pathogenic bacteria also comprises Burkholderia cepacia, described trichophyton rubrum and described primary cepacia The mass ratio of Kholderia is 4-8:3-5. 4.一种如权利要求1所述的抗多种致病菌组合物的制备工艺,其特征在于,其包括以下步骤:4. a preparation process of anti-multiple pathogenic bacteria composition as claimed in claim 1, is characterized in that, it comprises the following steps: 制备包含红色毛癣菌、絮状表皮癣菌、白色念珠菌、金黄色葡萄球菌、大肠杆菌、绿脓杆菌的复合抗原;Preparation of complex antigens comprising Trichophyton rubrum, Epidermophyton flocculus, Candida albicans, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa; 用所述复合抗原对鸡进行强化免疫,得到免疫鸡的免疫鸡蛋;Using the composite antigen to boost immunization of chickens to obtain immunized eggs of immunized chickens; 将所述免疫鸡蛋的蛋黄提取获得粗提物干粉;Extracting the egg yolk of the immunized egg to obtain dry powder of the crude extract; 将所述粗提物干粉通过离子交换层析和凝胶过滤层析分离纯化,得到抗多种致病菌组合物。The dry powder of the crude extract is separated and purified by ion exchange chromatography and gel filtration chromatography to obtain the anti-multiple pathogenic bacteria composition. 5.一种如权利要求1所述的抗多种致病菌组合物的应用,其特征在于,所述抗多种致病菌组合物制备用于预防和治疗足癣的制剂,所述制剂为喷雾剂、乳膏剂或洗剂。5. an application of anti-multiple pathogenic bacteria composition as claimed in claim 1, is characterized in that, described anti-multiple pathogenic bacteria composition prepares the preparation that is used for preventing and treating tinea pedis, and described preparation Available as a spray, cream, or lotion. 6.一种喷雾剂,其特征在于,其是由原料制备而成,所述原料包括:6. A spray, characterized in that it is prepared from raw materials, and the raw materials include: 用注射用水补至1000ml。Make up to 1000ml with water for injection. 7.根据权利要求6所述的喷雾剂,其特征在于,所述原料还包括1-5g中药提取液,所述中药提取物是采用包括大蒜、千里光、金银花、虎杖的中草药提取得到。7 . The spray according to claim 6 , wherein the raw material further comprises 1-5 g of Chinese medicine extract, and the Chinese medicine extract is obtained by extracting Chinese herbal medicines including garlic, Senecio, honeysuckle, and Polygonum cuspidatum. 8.根据权利要求6所述的喷雾剂,其特征在于,所述原料还包括1-5g左氧氟沙星。8. The spray according to claim 6, characterized in that, the raw material also comprises 1-5g levofloxacin. 9.一种如权利要求6所述的喷雾剂的制备工艺,其特征在于,其包括以下步骤:9. a preparation process of spray as claimed in claim 6, is characterized in that, it comprises the following steps: 将抗多种致病菌组合物、悬浮剂加入部分注射用水中搅拌溶解,得到混合液;adding the anti-multiple pathogenic bacteria composition and suspending agent into part of the water for injection and stirring to dissolve to obtain a mixed solution; 将冰片加乙醇溶解,再加入甘油混匀,再加入所述混合液,最后用注射用水补足至1000ml,得到药液;Dissolve the borneol in ethanol, add glycerin and mix evenly, then add the mixed solution, and finally make up to 1000ml with water for injection to obtain the medicinal solution; 将所述药液在灌装线上灌装手动定量压力喷雾罐50支,每支20ml,再充入30%以上的抛射剂。The medicinal liquid is filled into 50 manual quantitative pressure spray tanks on the filling line, each 20ml, and then filled with more than 30% propellant. 10.根据权利要求9所述的喷雾剂的制备工艺,其特征在于,制备混合液时还加入1-5g中药提取液,所述中药提取液的具体制备方法为:10. the preparation process of spray according to claim 9 is characterized in that, also add 1-5g Chinese medicine extract when preparing mixed solution, the concrete preparation method of described Chinese medicine extract is: 将清洗后的大蒜、千里光、金银花、虎杖用水提取至少两次,合并提取液经高速离心机离心,得第一离心液;extracting the washed garlic, senecio, honeysuckle, and knotweed with water at least twice, and centrifuging the combined extracts in a high-speed centrifuge to obtain the first centrate; 将水提后的药渣用乙醇溶液回流提取至少一次,提取液经高速离心机离心,得第二离心液;The medicinal dregs after water extraction are extracted at least once with ethanol solution under reflux, and the extract is centrifuged in a high-speed centrifuge to obtain a second centrate; 合并第一离心液和第二离心液,得到中药提取液。Combine the first centrifugate and the second centrifuge to obtain the Chinese medicine extract.
CN201810983400.7A 2018-08-27 2018-08-27 Composition for resisting various pathogenic bacteria, preparation process and application thereof, spray and preparation process thereof Active CN109010823B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810983400.7A CN109010823B (en) 2018-08-27 2018-08-27 Composition for resisting various pathogenic bacteria, preparation process and application thereof, spray and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810983400.7A CN109010823B (en) 2018-08-27 2018-08-27 Composition for resisting various pathogenic bacteria, preparation process and application thereof, spray and preparation process thereof

Publications (2)

Publication Number Publication Date
CN109010823A true CN109010823A (en) 2018-12-18
CN109010823B CN109010823B (en) 2022-03-18

Family

ID=64624736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810983400.7A Active CN109010823B (en) 2018-08-27 2018-08-27 Composition for resisting various pathogenic bacteria, preparation process and application thereof, spray and preparation process thereof

Country Status (1)

Country Link
CN (1) CN109010823B (en)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62181797A (en) * 1986-02-04 1987-08-10 Zenkoku Nogyo Kyodo Kumiai Rengokai Production of protein antigen produced by pathogenic bacteria of domestic animal or fowl
CN1331700A (en) * 1998-11-16 2002-01-16 基因纬生物技术公司 Generation of antibodies using polynucleotide vaccination in avian species
CN1569896A (en) * 2003-07-18 2005-01-26 广州新崴生物医药科技有限公司 Preparation of composite specific yelk antibody igy against cutaneous infection and its use in treatment of cutaneous infection
US20070071795A1 (en) * 2005-09-16 2007-03-29 Maiti Pradip Antibodies as Growth Promoting Agents
CN101554414A (en) * 2008-04-09 2009-10-14 北京大北农动物保健科技有限责任公司 Traditional Chinese medicine mixture for treating livestock and poultry virosis and preparation method thereof
CN101690812A (en) * 2009-10-21 2010-04-07 辽宁益康生物制品有限公司 Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
US20110171267A1 (en) * 2001-08-27 2011-07-14 Bourinbaiar Aldar S Anti-fungal composition
CN102898518A (en) * 2011-07-25 2013-01-30 深圳雅臣生物科技有限公司 Preparation method for special anti-bovine mastitis pathogenic microorganism IgY
CN104013958A (en) * 2014-04-30 2014-09-03 广州汇高生物科技有限公司 Specificity yelk immune globulin composition for preventing pathogenic bacteria and preparation thereof
CN106279349A (en) * 2016-08-31 2017-01-04 广东工业大学 For preparing extracting method and the preparation method of yolk antibody thereof of the dermatophytosis suppressor proteins antigen of yolk antibody
CN106397586A (en) * 2016-08-31 2017-02-15 广东工业大学 Anti-dermatophyte specific yolk antibody, preparation method and application thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62181797A (en) * 1986-02-04 1987-08-10 Zenkoku Nogyo Kyodo Kumiai Rengokai Production of protein antigen produced by pathogenic bacteria of domestic animal or fowl
CN1331700A (en) * 1998-11-16 2002-01-16 基因纬生物技术公司 Generation of antibodies using polynucleotide vaccination in avian species
US20110171267A1 (en) * 2001-08-27 2011-07-14 Bourinbaiar Aldar S Anti-fungal composition
CN1569896A (en) * 2003-07-18 2005-01-26 广州新崴生物医药科技有限公司 Preparation of composite specific yelk antibody igy against cutaneous infection and its use in treatment of cutaneous infection
US20070071795A1 (en) * 2005-09-16 2007-03-29 Maiti Pradip Antibodies as Growth Promoting Agents
CN101554414A (en) * 2008-04-09 2009-10-14 北京大北农动物保健科技有限责任公司 Traditional Chinese medicine mixture for treating livestock and poultry virosis and preparation method thereof
CN101690812A (en) * 2009-10-21 2010-04-07 辽宁益康生物制品有限公司 Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
CN102898518A (en) * 2011-07-25 2013-01-30 深圳雅臣生物科技有限公司 Preparation method for special anti-bovine mastitis pathogenic microorganism IgY
CN104013958A (en) * 2014-04-30 2014-09-03 广州汇高生物科技有限公司 Specificity yelk immune globulin composition for preventing pathogenic bacteria and preparation thereof
CN106279349A (en) * 2016-08-31 2017-01-04 广东工业大学 For preparing extracting method and the preparation method of yolk antibody thereof of the dermatophytosis suppressor proteins antigen of yolk antibody
CN106397586A (en) * 2016-08-31 2017-02-15 广东工业大学 Anti-dermatophyte specific yolk antibody, preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
孙丰雷等: "《常见皮肤病中药外治方》", 30 September 2011, 人民军医出版社 *
杨维萍: "《实用临床外科常见病理论与实践》", 30 June 2018, 科学技术文献出版社 *

Also Published As

Publication number Publication date
CN109010823B (en) 2022-03-18

Similar Documents

Publication Publication Date Title
CN100553665C (en) A kind of Chinese medicine medicine for the treatment of pharyngolaryngitis
CN103750324B (en) A kind of milk basic protein Hericium erinaceus powder composite sheet
WO2018176647A1 (en) Chinese medicine for treating thiamine deficiency
CN104739925A (en) Composition for treating acnes and preparation method for composition
CN107158209A (en) It is a kind of to treat herbal mixture biofermentation preparation of bird flu and preparation method thereof
KR100894439B1 (en) Cosmetic composition having a prophylactic effect of atopic dermatitis and method for producing same
CN105748545B (en) Application of a kind of Sanqi root transformed saponin in the preparation of antifungal Epidermophyton floccosum, Trichophyton rubrum and Trichophyton mentagrophytes
KR20190092038A (en) A antibacterial composition containing the extracts of silk tree bark and the feminine cleanser composition comprising the same
Rimple et al. Poly pharmacological effects of green blood therapy: An update
CN110898201A (en) A kind of external use traditional Chinese medicine composition for children and its preparation method
CN109010823A (en) Anti- various pathogens composition and its preparation process and application, spray and its preparation process
CN101588810A (en) Composition comprising trachelospermi caulis and pyrola japonica extracts for treating and preventing inflammatory diseases
CN104000919B (en) A kind of Chinese medicine composition
RU2382652C1 (en) Therapeutic preparation for young growth of agricultural animals and method for prevention and treatment of gastrointestinal diseases of calves with its application
CN106138215A (en) A kind of medicine for treating eczema
RU2423996C1 (en) Method of phytopreparation therapy of gastrointestinal diseases in calves
CN118121652B (en) A kind of plant essential oil formula for treating rhinitis and preparation method
CN108653729A (en) A kind of vaginal foam agent and its application
CN103690771B (en) Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof
WO2018176642A1 (en) Chinese medicine for treating skin inflammation
CN102357199A (en) Traditional Chinese medicine for treating manus and tinea pedis
CN101314026B (en) Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof
FI60645B (en) FOERFARANDE FOER FRAMSTAELLNING AV VAEXTEXTRAKT FOER SKOETSEL AV ASTMA SNUVA OCH / ELLER HOSTA
Randall Historical and modern uses of Urtica
CN101234140A (en) A kind of pharmaceutical composition for treating eczema and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 510507 Guangdong Province Guangzhou City Tianhe District Shatai South Road 268 8th Floor 8011 Room

Patentee after: GUANGZHOU HUIGAO BIOTECHNOLOGY CO.,LTD.

Country or region after: China

Address before: 510507 room 701, No. 68, yueken Road, Tianhe District, Guangzhou City, Guangdong Province (part: self compiled 03) (office use only)

Patentee before: GUANGZHOU HUIGAO BIOTECHNOLOGY CO.,LTD.

Country or region before: China

CP03 Change of name, title or address